Hillhouse Capital-backed innovative biopharmaceutical company Shanghai Junshi Biosciences Co., Ltd is targeting to raise 4.8 billion yuan ($684 million) in its initial public offering on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE), per a company filing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
